Novo Nordisk becomes a BaseLaunch partner
Basel, 18.12.2023
BaseLaunch, the Basel area-based biotech venture accelerator and incubator established in 2017, today announces that global healthcare company Novo Nordisk has become the latest partner to join BaseLaunch.
Novo Nordisk joins other world-class pharma, venture fund and biotechnology partners – Roche, Johnson & Johnson, CSL Behring, Pureos Bioventures, CMS, Roivant Sciences and Bridge Biotherapeutics – in supporting BaseLaunch’s mission to build the next generation of innovative biotech companies. This will strengthen BaseLaunch’s global pharma industry ties and further enhance its ability to deliver tangible results for scientists and entrepreneurs developing innovative biotech companies.
To date, BaseLaunch has supported multiple successful early-stage biotech ventures from inception to Series A funding, providing financing and assisting in all aspects of company development. Of the 22 ventures supported by BaseLaunch since 2018, ten have so far collectively raised over USD 600 million in equity capital, with six ventures to date having entered clinical development. Boehringer Ingelheim’s recent USD 500 million acquisition of T3 Pharma, one of the first companies supported by BaseLaunch, exemplifies BaseLaunch’s standing as a world-leader in building biotech ventures and is a testament to the strength of the Basel region, arguably Europe’s most dynamic life sciences hub.
Stephan Emmerth, Director Business Development & Operations at BaseLaunch, said: “Novo Nordisk brings a wealth of industry experience which is invaluable to life sciences innovation. We are continually impressed by the quality of science and people that we can access, and the results that our ventures are achieving are truly inspiring. We look forward to building yet more breakthrough biotech companies and expanding the overall scope of BaseLaunch with the support of our partners.”
BaseLaunch is operated by Basel Area Business & Innovation, the investment and innovation promotion agency of the Basel region. BaseLaunch has partnered with a diverse group of international life sciences organisations with the aim of harnessing the Basel area’s unique position as a global life sciences hub, as well as its rising popularity among investors, to attract the next generation of breakthrough companies..
About BaseLaunch
BaseLaunch is the Basel area-based incubator and accelerator that helps scientists and entrepreneurs launch exceptional biotech companies. BaseLaunch serves as a growth platform for early-stage ventures developing cutting-edge therapeutics. BaseLaunch helps build companies from inception through to Series A funding, providing financing and supporting all aspects of business development. It is operationally run and financed by Basel Area Business & Innovation, the investment and innovation promotion agency of the Basel region. BaseLaunch partners with leading global pharma and biotech companies and a venture fund – Roche, Pureos Bioventures, Roivant Sciences, Bridge Biotherapeutics, CSL Behring, Johnson & Johnson, CMS and Novo Nordisk – which also feed into the pool out of which BaseLaunch funds ventures.
Domain and regional partners include KPMG, Vossius & Partner, Walder Wyss attorneys at law, WuXi AppTec, Lonza, Charles River Laboratories, Schrödinger, Wuxi Biologics, as well as the Tech Park Basel, the Switzerland Innovation Park Basel Area. Since 2018, BaseLaunch supported ventures have raised in total over USD 600 million. Harnessing the Basel area’s unique position as a global life sciences hub, as well as its rising popularity among investors, BaseLaunch is looking to attract the next generation of breakthrough companies. Interested groups can find more information at www.baselaunch.ch.
About Basel Area Business & Innovation
Basel Area Business & Innovation is the investment and innovation promotion agency dedicated to helping companies, institutions and startups find business success in the Basel area. The organization targets and attracts companies to settle, supports founders of innovative ventures, and drives high growth initiatives in order to establish the region as the Swiss business and innovation hub of the future. The non-profit agency focuses on growing the area’s cutting-edge industries life sciences, healthcare and production technologies and manages the Switzerland Innovation Park Basel Area which houses the organization’s accelerators. The agency serves the cantons of Basel-Landschaft, Basel-Stadt and Jura.
